L
Leonard M. Shapiro
Researcher at Papworth Hospital
Publications - 134
Citations - 7025
Leonard M. Shapiro is an academic researcher from Papworth Hospital. The author has contributed to research in topics: Mitral valve & Coronary artery disease. The author has an hindex of 44, co-authored 132 publications receiving 6646 citations. Previous affiliations of Leonard M. Shapiro include Hammersmith Hospital & Tufts University.
Papers
More filters
Journal ArticleDOI
Cardiac tumours: diagnosis and management
TL;DR: Cardiac tumours are diverse in clinical presentation, and atrial myxomas in particular may cause systemic symptoms mimicking collagen vascular disease, malignancy or infective endocarditis; there are several clinical features that are seen commonly with many cardiac tumours.
Journal ArticleDOI
Association Between IVUS Findings and Adverse Outcomes in Patients With Coronary Artery Disease: The VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study
Patrick A. Calvert,Daniel R. Obaid,Daniel R. Obaid,Michael O'Sullivan,Leonard M. Shapiro,Duncan C. McNab,Cameron G. Densem,Peter R. Schofield,Denise Braganza,Sarah C. Clarke,Kausik K. Ray,Nick E.J. West,Martin R. Bennett +12 more
TL;DR: VH-IVUS TCFA was associated with nonrestenotic and total MACE on individual plaque analysis, and noncalcified VHTCFA wasassociated with nonRestenoticand total Mace on whole-patient analysis, demonstrating that VH- IVUS can identify plaques at increased risk of subsequent events.
Journal ArticleDOI
Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study A Prospective, Randomized Control Trial
Stephen P. Hoole,Patrick M. Heck,Linda D. Sharples,Sadia N. Khan,Rudolf Duehmke,Cameron G. Densem,Sarah C. Clarke,Leonard M. Shapiro,Peter R. Schofield,Michael O'Sullivan,David P. Dutka +10 more
TL;DR: Remote IPC reduces ischemic chest discomfort during PCI, attenuates procedure-related cTnI release, and appears to reduce subsequent cardiovascular events.
Journal ArticleDOI
Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study.
TL;DR: The proportion of patients with symmetric and distal ventricular hypertrophy was greater than that reported when patients are selected on the basis of M-mode diagnostic criteria and suggests that the recognition and understanding of hypertrophic cardiomyopathy have been biased by patients with asymmetric septalhypertrophy who previously were most readily identified.
Journal ArticleDOI
Results of prevention of REStenosis with tranilast and its outcomes (PRESTO) trial
David R. Holmes,Michael P. Savage,J. M. LaBlanche,Lars Grip,Patrick W. Serruys,Peter J. Fitzgerald,David L. Fischman,Sheldon Goldberg,Jeffrey A. Brinker,A. M. Zeiher,Leonard M. Shapiro,James T. Willerson,Barry R. Davis,James J. Ferguson,Jeffrey J. Popma,Spencer B. King,A. Michael Lincoff,James E. Tcheng,Robert Chan,Granett Jeffrey R,Marcia Poland +20 more
TL;DR: Tranilast does not improve the quantitative measures of restenosis (angiographic and intravascular ultrasound) or its clinical sequelae and is not able to reduce the risk of major adverse cardiovascular events.